July 20, 2021
Shionogi has gotten its hands on nasal vaccine candidates for COVID-19 developed by HanaVax, a startup originating from the University of Tokyo, obtaining their exclusive worldwide rights for an undisclosed sum. The two companies said on July 19 that they...read more